Bayer, Samsung, Pepsi, Smartphones: Intellectual Property

March 5 (Bloomberg) -- Bayer AG plans to appeal a ruling by an Indian regulatory board that allows generic-drug maker Natco Pharma Ltd. to make a low-priced copy of Bayer’s patented Nexavar cancer medicine.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.